País: Israel
Idioma: inglés
Fuente: Ministry of Health
COLESTIPOL HYDROCHLORIDE
PFIZER PFE PHARMACEUTICALS ISRAEL LTD
B04AD
GRANULES
COLESTIPOL HYDROCHLORIDE 5 G/SACHET
PER OS
Required
FARMEA, FRANCE
Adjunctive therapy to diet in the managnent of elevated cholesterol levels.
2014-08-31
ةرارملا يف ىصح ،ةرارملا سيك باهتلا �امد أيقتت امبر وأ ادج انكاد زاربلا ةحبذ) ردصلا يف طغض وأ جاعزنا ،ردصلا يف ملاآ �ةرفصلا ىلإ لئام دلج وأ يف قيض �(tachycardia) عيرس ضبن ،(angina pectoris ،ةيردص تايوتسم �دلجلا باهتلا ،ىرش وأ دلجلا يف ةكح �سفنتلا يف تابوعص وأ سفنتلا ىوتسم عافترا ،نينلالأا نيمأ ةلقان عافترا) دبكلا تاميزنلإ ةميلس ريغ وأ ةعفترم ةنيعم ةدام) مدلا يف ّ يولقلا زاتفسوفلا ىوتسم عافترا �(تاتراپسلأا نيمأ ةلقان �(ةيطيحم ةمذو) نيديلا عباصأ وأ نيمدقلا يتحار ،نيلحاكلا مروت ،(مدلا يف .فعضلاب روعش ضعب يفو تاينهدلا كمسج اهيف صتمي يتلا ةقيرطلا يف ™ ديتسيلوك رثؤي ل ّ مكم لوانتب بيبطلا ىصوي دق .( K و A ,D ,E ) نهدلا يف ةبئاذلا تانيماتيفلا .ثدحت دق ةلاحلا هذه نأ دقتعي ناك اذإ تانيماتيفلا نم ةتقؤم نوكت ةلاحلا هذه .مدلا يف تانيماتيفلاو تاينهدلا ىوتسم عفتري نأ ل َ متح ُ ي .ابلاغ نم تيناع اذإ وأ ةيبناجلا ضارعلأا نم يأ مقافت اذإ ،يبناج ضراع رهظ اذإ .بيبطلا ةراشتسا كيلع ،ةرشنلا يف ركذ ُ ي مل يبناج ضراع طبار ىلع طغضلا ربع ةيبناجلا ضارعلأاب ة ّ حصلا ةرازو غلابإ نكمي ةحفصلا يف دوجوملا ،"يئاودلا جلاعلا ببسب ةيبناجلا ضارعلأا نع غلابلإا" ىلإ كهجوي يذلا ،( www.health.gov.il ) ة ّ حصلا ةرازو عقومل ةيسيئرلا ىلإ لوخدلا ربع وأ ،ةيبناجلا ضارعلأا نع غلابلإل تنرتنلإا Leer el documento completo
Colestid LPD CC 281120 Page 1 of 5 2013-0002201 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Colestid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains 5 g of colestipol hydrochloride. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Granules for oral suspension. Yellow to orange colored free-flowing beads 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Colestid is indicated as adjunctive therapy to diet in the management of elevated cholesterol levels. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Treatment for elevated serum cholesterol levels should begin with dietary therapy. A minimum of six months of dietary therapy and counseling should usually be undertaken before initiating drug therapy; shorter periods can be considered in patients with severe elevations of LDL-cholesterol (>225 mg/dl or 5.8 mmol/L) or definite Coronary Heart Disease. Drug therapy should be added to dietary therapy, and not substituted for it. Colestipol hydrochloride granules should never be taken in dry form. Esophageal spasm or respiratory distress can result from attempting to swallow the granules dry. Route of administration: Oral, mixed with water or other fluids. Adults: The recommended initial daily adult dosage of colestipol hydrochloride is 5 grams either once or twice daily. For adults colestipol hydrochloride is recommended in doses of 5 - 30 grams taken as one dose or two divided doses. Initiation of therapy is recommended at 5 grams either once or twice daily with 5 gram increments at one month intervals. Appropriate use of lipid profiles including LDL-cholesterol and triglycerides is advised so that optimal, but not excessive doses are used to obtain the desired therapeutic effect on LDL-cholesterol level. If the desired therapeutic effect is not obtained at a dose of 5 - 30 grams/day with good compliance and acceptable side-effects, combined therapy or alternate treatment should be considered. Patients should take other drugs at least one hour before or four Leer el documento completo